Naphthalene exposure kills lung airway epithelial (Clara) cells, but is rapidly followed by Clara cell reconstitution coincident with proliferation of pulmonary neuroendocrine cells (PNEC). Although a role for mature PNEC in the reconstitution process has been excluded, the reconstituting progenitor cells have been suggested to enter a transient neuroendocrine (NE) differentiation phase before differentiating to Clara cells. Furthermore, these progenitors were suggested to be the target population for transformation to a NE tumor; small cell lung cancer (SCLC). Although the NE phenotype is central to SCLC oncogenesis, the relevance of NE differentiation to post naphthalene reconstitution remains to be determined. The Growth factor independent-1 (Gfi1) transcription factor is expressed in SCLC and is required for the NE differentiation of PNEC. Gfi1 À/À mice display a 70% reduction in airway cells that express NE markers, and cells that stain for NE markers show weak expression of some markers. Therefore, to determine the relevance of the NE phenotype to post-naphthalene reconstitution, we examined post-naphthalene reconstitution in Gfi1 À/À mice. Our analyses indicate that the post-naphthalene regeneration process includes both airway epithelial proliferation and apoptosis. Gfi1 deletion lowered both airway epithelial proliferation and apoptosis; however, the post-naphthalene rate of increase in growth and apoptosis was not significantly different between Gfi1 À/À mice and wild-type littermates. Moreover, the timing and extent of CC10 þ cell regeneration was unaffected by Gfi1 deletion. These data suggest that neither Gfi1 nor the NE phenotype play a dominant role in the regeneration process. However, the few Gfi1 À/À cells capable of NE differentiation show a significant reduction in post-naphthalene proliferation. The modest proliferation seen in Gfi1 À/À NE cells is consistent with the previously proposed role for Gfi1 in controlling neuroendocrine cancer growth.
Pulmonary neuroendocrine cells (PNEC) are a rare population that reside in the bronchiolar epithelium and are characterized by their ability to secrete amines and peptides that act as growth and regulatory factors.
1 PNEC are present as dispersed single cells or as clusters of cells referred to as neuroepithelial bodies (NEB). NEB are highly innervated and are believed to act as intrapulmonary chemoreceptors, sensitive to hypoxia and to perform several suggested 'corpuscular' functions such as nociceptive signal transmission and mechanosensation. [2] [3] [4] [5] Pulmonary damage caused by chronic lung diseases, hypoxia, hyperoxia, extended exposure to environmental pollutants such as tobacco smoke, nitrosamines, ozone and naphthalene induces PNEC proliferation. 6, 7 Naphthalene is an aromatic hydrocarbon that is a constituent of tobacco smoke. 8 Naphthalene specifically ablates the non-ciliated epithelial Clara cells that are most abundant in the bronchiolar epithelium. 9 Cytochrome P450-2F2-isozyme oxidizes naphthalene in Clara cells into naphthalene 1R, 2S epoxide, which is highly toxic to cells. 10 Non-Clara cells of the airways lack this cytochrome P450 enzyme and therefore naphthalene administration to mice specifically ablates only Clara cells. Following naphthalene-induced ablation of Clara cells, the airway epithelium undergoes a dynamic reconstitution and repopulation in the injured airways. Clara cell reconstitution post-naphthalene induced ablation is associated with PNEC and NEB hyperplasia. 6, 11, 12 Lung injury as a result of naphthalene administration provides a model to study the dynamics of reconstitution and to characterize progenitor cells responsible for the repair of injured lungs. 6, 9, [11] [12] [13] [14] [15] The naphthalene injury and repair model has been utilized to define progenitors responsible for injury recovery and reconstitution of depleted epithelial cells. 11, 12, [16] [17] [18] [19] [20] The NEB hyperplasia associated with naphthalene injury suggests a possible role for the PNEC in the reconstitution process. 11, 12, 16 However, more recent data indicate that PNEC themselves are incapable of Clara cell reconstitution of the airways. 16, 17, 19 It has been suggested that the NEB microenvironment serves as a reservoir for a variant Clara cell that (1) lacks cytochrome P450-2F2-isozyme activity rendering it resistant to naphthalene toxicity and (2) may be capable of proliferating and repopulating the injured lungs. 16, 17 Several other progenitors and niches have been described as potential contributors to the post-naphthalene reconstitution of Clara cells. [18] [19] [20] [21] For example, in the trachea and larger airways basal cells have the ability to proliferate and might contribute to the recovery process after naphthalene-induced Clara cell ablation. 19, 21 In addition, distinct from the NEB microenvironment, naphthalene-resistant Clara cells at the terminal bronchioalveolar duct junctions represent another potential contributor to the restoration of the injured epithelium. 18 More recently, a progenitor at the bronchioalveolar duct junction was characterized, which was hypothesized to repopulate both damaged Clara and alveolar cells. 20 The presence of several putative progenitors indicates the complexity of the process.
Extensive activation of the hedgehog (Hh) pathway has been suggested to immediately precede both neuroendocrine (NE) differentiation during post-naphthalene reconstitution, and normal differentiation of pulmonary NE precursor cells. 22 Watkins et al 22 proposed that some types of small cell lung cancer (SCLC) may recapitulate the NE differentiation phase of Hh-dependent airway epithelial reconstitution. Thus, cells similar to the post naphthalene reconstituting cells were suggested to be the target population for transformation to SCLC. Although the NE phenotype is central to SCLC oncogenesis, the relevance of NE differentiation to postnaphthalene reconstitution remains to be determined.
The Growth factor independent-1 (Gfi1) transcriptional repressor was first described as a target of insertion mutagenesis in Moloney murine virus induced leukemias. [23] [24] [25] [26] Senseless, the Drosophila orthologue of Gfi1, is essential for fly sensory organ development. Senseless functions as a downstream effector of proneural basic helix-loop-helix (bHLH) proteins in antagonism to Notch. 27 Similar interactions between Gfi1 and proneural bHLH exist in the mammalian sensory organs such as the ear and the retina. [27] [28] [29] [30] We recently reported the expression of Gfi1 and the proneural bHLH factor Achaete scute homolog-1 (mASH1) in both embryonic and adult mouse PNEC, and NE tumor cell lines. 28, 31 Indeed, although Gfi1 deletion in mouse PNEC did not affect mASH1 expression, lack of Gfi1 resulted in dramatically reduced expression of NE markers such as calcitonin gene-related peptide (CGRP) and synaptophysin (SYN). Similarly, a strong correlation exists between expression of Gfi1, ASH1 and NE markers in primary human lung tumors. 31 Thus, Gfi1 plays an important role in the differentiation and proper maturation of PNEC, and lack of Gfi1 significantly decreases the NE phenotype of airway cells. 31 Given the proposed link between NE differentiation in post naphthalene repair and SCLC oncogenesis, the expression of Gfi1 in SCLC, and the significant impairment of NE marker expression in Gfi1 À/À mice, we tested whether Gfi1
NE cells respond to post-naphthalene cues, and whether the reduced NE environment in Gfi1 null mice affects repair. Although deletion of Gfi1 reduced NE differentiation, NE cell proliferation, and airway epithelial proliferation and apoptosis, the post-naphthalene rate of increase in proliferation and apoptosis was not de-regulated. Thus, the regeneration process was not visibly affected. Our data suggest that neither Gfi1 nor the NE phenotype play a dominant role in the regeneration process.
MATERIALS AND METHODS Animals and Treatment
Wild-type (wt) and Gfi1 À/À mice on a C57Bl/6 background were used at 2-months of age. Groups of wt and Gf1 null littermates were utilized throughout the study. Naphthalene (Sigma, St Louis, MO, USA) was dissolved in corn oil and administered intraperitoneally as described previously. 11 Wt and Gfi1 À/À control mice were injected similarly with corn oil alone. The mice were killed 3 or 5 days following treatment. Two hours before death, bromo-deoxyuridine (BrdU) (Sigma) was administered. All control and experimental animals received BrdU. BrdU was dissolved in water at 10 mg/ml and administered intraperitoneally at 10 mg/g body weight.
Lung Fixation and Tissue Collection Mice were killed, and the lungs were harvested after formalin fixation as previously described with minor modifications. 11 Right lung lobes were fixed by inflation at 10 cm H 2 O with neutral-buffered Formalin instilled through a tracheal cannula. 11 The harvested lungs were further fixed in 10% neutral-buffered formalin (Surgipath, Richmond, IL, USA) overnight at room temperature. The 10% neutral buffered formalin was replaced with 70% ethanol and the tissues were embedded into paraffin.
Immunohistochemistry
Paraffin-embedded tissue sections were deparaffinized, hydrated and stained using the Vectastain ABC kit (Vector Laboratories, Burlingame, CA, USA) following the vendor's instructions with modifications as described. 32 Rabbit anti-CGRP (1:3000, Amersham Biosciences, Piscataway, NJ, USA) and rabbit anti SYN (1:100, Zymed, San Fransisco, CA, USA) antibodies were employed to evaluate NE differentiation, whereas rabbit anti-Clara cell 10 kDa secretory protein (CC10) (1:100 000, Dr Franco DeMayo, Baylor School of Medicine, Houston, TX, USA) was used to identify the major secretory product of the Clara cell, a signature of epithelial cell differentiation within the conducting airways. A rat antiBrdU antibody (1:300, Accurate Chemical, Westbury, NY, USA) was used to detect BrdU incorporation in cells undergoing proliferation. Following immunohistochemical staining NE differentiation was quantified by counting the positive foci composed of solitary PNEC and NEBs containing CGRP or SYN in airways. NE expression was computed for each animal by dividing the number of positive NE foci (solitary PNEC or NEBs) by the total number of airways analyzed (Foci/Airway Ratio or F/A). CC10 immunostaining pattern was assessed using a staining index as described previously, 33 which combines the intensity and distribution of positive cells.
Morphometric Analysis of Proliferation and Apoptosis
Apoptotic index was determined by the TUNEL assay using the Apoptag Plus Peroxidase in situ Detection Kit (Chemicon International, Inc., Temecula, CA, USA). according to the vendor's instructions. Quantification of BrdU incorporation and TUNEL staining was assessed using MetaMorph imaging software (Universal Imaging, Westchester, PA, USA) with a Â 20 objective (Nikon Eclipse E400 Microscope). A labeling index (LI) for airway epithelial cells was derived by dividing the total number of positive nuclei by 1000, the total number of cells analyzed per animal.
In addition to the overall labeling index, terminal bronchioles were defined as described previously, 18 and cells located 200 mm from the bronchioloalveolar junction were analyzed. To determine the rate of BrdU incorporation in NE cells adjacent sections placed on the same slide were stained for CGRP and BrdU and the percentage of labeled PNEC and NEBs was established.
Statistical Analysis
Mean values for all parameters were compared with control values using the Mann-Whitney Rank sum test unless indicated otherwise. Statistical significance for all comparisons was acknowledged when P-values were o0.05. The comparison of the fold-change between wt and Gfi1 À/À were determined using two-way ANOVA. The factors were treatment (naphthalene vs oil) and type (wt vs Gfi1 À/À mice). A variance stabilizing transform function was used for the percentages (the arcsin square root). With this model, a significant interaction would mean that the effect of treatment (naphthalene vs oil) will be different depending on type (wt vs Gfi1 À/À ). This model does not test whether the ratios are different between the two types, but tests whether the magnitude of the effect measured on the transformed scale (arcsin square root of percent) are different between the two types. The SPSS statistical software (SPSS Inc. Chicago, IL) was used for performing the two-way ANOVA analysis.
RESULTS

Differentiated Gfi1
À/À PNEC Proliferate Poorly, but Respond Normally to Naphthalene-Induced Lung Injury We have determined previously that Gfi1 is expressed in embryonic and adult PNEC and that lack of Gfi1 expression resulted in reduced numbers of of CGRP and SYN expressing cells. 28, 31 In contrast, the number of Ash1 expressing cells in Gfi1 À/À mice remained the same. 28, 31 As Ash1 is critically required for PNEC development, 34 Gfi1 might be required for maturation of presumptive PNEC. 28, 31 Interestingly, some PNEC were able to differentiate in the absence of Gfi1, but could only weakly express CGRP and SYN. To determine the relevance of the NE phenotype to the post-naphthalene reconstitution process, we determined CGRP and SYN expression in naphthalene injured airway epithelium of wt and Gfi1 À/À mice 3 or 5 days following naphthalene administration. These time points are likely to be most informative for assessing NE differentiation. 6, 12 Immunohistochemical detection of CGRP and SYN in oil-administered mice was used as a control (Figure 1a) . Following naphthalene injury the number of PNEC increased. 6, 12 In our experiments, control mouse CGRP and SYN-positive cells within bronchioles increased in numbers, peaking 5 days following naphthalene administration (Figure 1a) . 6, 12 Similar immunohistochemical analysis of Gfi1 À/À mice show that the 2-3-fold increase in numbers of CGRP and SYN positive foci in wt vs Gfi1 À/À mice was not statistically different (compare Figures 1a and b) . Thus, whereas few PNEC differentiate without Gfi1, those that do are capable of responding to naphthalene-induced reconstitution signals. 
CGRP SYN
The increase in NE cells post-naphthalene exposure does not rescue the impact of Gfi1 À/À on PNEC development. As expected, immunohistochemical staining showed a significant decrease of CGRP staining in oil-administered Gfi1 À/À mice than in the oil-administered wt mice (P ¼ 0.012) (Figure 1c) . A similar decrease was observed in SYN expression in oil-administered Gfi1 À/À mice than in the oil-administered wt mice. In agreement with previous observations of postnaphthalene reconstitution, 6 ,12 a significant increase in CGRP expressing NE cell foci within bronchiolar epithelium was observed in wt mice 3 (P ¼ 0.016) and 5 (P ¼ 0.032) days following naphthalene administration compared with oiltreated animals (data not shown). A similar increase in CGRP-containing foci was seen in Gfi1 À/À mice 3 (P ¼ 0.002) and 5 (P ¼ 0.019) days following naphthalene administration compared with oil-administered animals (data not shown). However, the post-naphthalene environment did not rescue Gfi1 À/À defects, because when Gfi1 À/À mice were compared with wt mice 5 days following naphthalene administration, there was still a significant reduction in CGRP expressing NE foci (P ¼ 0.014) in the Gfi1 À/À animals ( Figure 1c ). Similar to the increase in CGRP-positive NE foci following naphthalene administration, an increase in the wt SYN containing foci within bronchioli was observed compared with oil-treated mice. The increase in wt SYN-positive foci was significant 5 days following naphthalene administration compared with oil-treated mice (P ¼ 0.049) (data not shown). Gfi1 À/À mice also showed a significant increase in SYN-positive cells 5 days after naphthalene treatment when compared with oil-treated Gfi1 À/À animals (P ¼ 0.005) (data not shown). As expected from the differences in PNEC induced by Gfi1 loss, comparison of SYN staining in Gfi1 À/À mice and wt mice 5 days following naphthalene administration showed a significant difference between the two; Gfi1 À/À mice had less SYN-positive foci compared with wt mice (P ¼ 0.009) (data not shown).
A two-way ANOVA analysis indicated that whereas the increase in the number of CGRP or SYN expressing foci in each group (wt or Gfi1 À/À ) is significantly different after naphthalene administration, there is no evidence that either wt or Gfi1 À/À PNEC respond differently to naphthalene administration. Thus PNEC, which have managed to differentiate without Gfi1 respond to naphthalene treatment in a similar manner to normal PNEC.
To examine further the impact of Gfi1 loss on NE differentiation we analyzed BrdU incorporation within CGRP þ cells (PNEC and NEBs). We first counted BrdU þ NEBs. In wt mice approximately one out of five NEBs (18%) initially revealed one or more BrdU-labeled cells, increasing to two out of three NEBs (69%) 3 to 5 days post-naphthalene (data not shown). Next, we evaluated each individual CGRP þ cells for BrdU staining. The post-naphthalene increase in BrdU þ CGRP þ cells was significant (P ¼ 0.001), but transient (Figure 1d ). In contrast, BrdU þ NEBs were rarely seen in Gfi1 À/À mice, and after exposure to naphthalene only one out of three (35%) NEBs were also BrdU þ (data not shown). Similar to wt littermates, the post-naphthalene increase in individual Gfi1 À/À BrdU þ CGRP þ cells was transient (Figure 1d) . Notably, the 3-day post-napthalene BrdU staining in Gfi1 À/À airways was highly variable, and prevented the increase in BrdU þ NE cells from reaching statistical significance. Yet, the number of BrdU þ CGRP þ cells was lower in Gfi1 KO mice than wt littermates in both oil-treated controls, and at either 3 or 5 days after naphthalene (P ¼ 0.05) (Figure 1d ). The decreased BrdU labeling in Gfi1 À/À CGRP þ cells is consistent with a role for Gfi1 in mediating proliferation of NE cells. However, the Gfi1 À/À impairment of NE cell proliferation was not impacted by naphthalene treatment, as the naphthalene-induced rate of increase of the BrdU þ CGRP þ cells was not statistically different between wt and Gfi1 À/À littermates (P ¼ 0.8). In other words, Gfi1 À/À airway epithelial cells that are capable of NE differentiation proliferate less well than Gfi1 expressing wt NE cells, but the naphthalene-induced rate of increase in the number of such cells was not impacted by loss of Gfi1.
Gfi1 Loss Decreases Post-Naphthalene Proliferation in Airway Epithelium
BrdU incorporation was also utilized to assess the role of Gfi1 loss on proliferation in the airway epithelium 3 and 5 days following naphthalene injury ( Figure 2 ). As expected, there was a significant increase in the overall epithelial cell proliferation rate in wt animals (Po0.001) whereas the response in Gfi1 À/À mice was attenuated (P ¼ 0.058; 27 fold vs sevenfold, respectively) (Figure 2e ). To characterize further post-naphthalene cellular dynamics, we focused on the terminal bronchioli, because this region comprises a putative regenerating zone harboring a stem cell niche. Immunohistochemical analysis of oil-administered wt or Gfi1 À/À mice revealed few cells actively proliferating in terminal bronchioli (Figures 2a and b) . Three days following naphthalene administration fewer cells were BrdU-positive in Gfi1 À/À mice compared with wt mice (Figure 2c and d) . Notably, the observed induction of post-naphthalene proliferation in terminal bronchioli was not significantly different between Gfi1
À/À and wt littermates. Similar to Gfi1 effects on NE cell proliferation, the Gfi1 À/À decrease in BrdU staining in terminal bronchioli was not reversed by naphthalene. Thus, whereas Gfi1 deletion decreases airway epithelial proliferation, the significance of Gfi1 deletion upon post-naphthalene proliferation is restricted to the proximal and distal airways.
We next examined apoptosis in terminal bronchioli. After naphthalene administration, there was a statistically significant increase in apoptotic (TUNEL þ ) cells both in wt and Gfi1
À/À mouse airway epithelial cells (Po0.02 and Po0.05, respectively; Welch T-test) (Figure 2f ). However, the difference between Gfi1 À/À and wt littermates in the postnaphthalene rate of increase in apoptosis was not statistically significant (Po0.1; Welch T-test) (Figure 2f ). In conclusion, our analyses have uncovered Gfi1
À/À defects in airway epithelia and NE cell biology, but ANOVA statistical analyses indicated that these defects do not interact with naphthalene treatment.
Clara Cell Lung Reconstitution is Efficient in Gfi1
À/À Mice Given a lack of statistical correlation between Gfi1 À/À defects and naphthalene treatment, we next examined whether lack of Gfi1 expression in murine lungs has an effect on Clara cell reconstitution. First, CC10 immunohistochemical staining of the distal airways 3 days following oil administration showed no initial difference between Gfi1 À/À and wt mice (Figures 3a  and b) . Moreover, Clara cells in the Gfi1 À/À airway are ablated similarly to wt littermate airway cells (Figure 3c ). Finally, similar to wt mice, Clara cells in Gfi1 À/À lungs were fully reconstituted by 5 days following naphthalene administration (Figure 3d) .
Quantification of CC10-positive cells showed no difference in staining between wt and Gfi1 À/À mice following oil treatment. A significant decrease was observed in both Gfi1 À/À and wt mice 3 days following naphthalene administration compared with oil-treated animals (Po0.001) (Figure 3e ), confirming successful ablation with naphthalene. Wt and Gfi1 À/À mice showed very similar Clara cell reconstitution with no difference observed between the two, 5 days following naphthalene treatment (Figure 3e) .
DISCUSSION
Discerning the mechanisms that are active during post-injury lung regeneration is crucial for decreasing the impact of injury from environmental insults or disease. Functional knockouts that delete cells expressing the CC10 marker were used previously to examine the process of naphthalene-induced lung injury and regeneration. 17 However, no previous studies have examined the response to naphthalene-induced injury in a model with impaired expression of NE differentiation or impaired PNEC development.
We have reported previously the requirement of Gfi1 for the proper differentiation of PNEC during development. 31 Others have implied that reconstitution following naphthalene exposure involves a wave of NE differentiation. 6, 22 The present study used the naphthalene-induced lung injury model to evaluate the functional consequences of impaired NE phenotype upon Clara cell reconstitution. 35 Following naphthalene injury, PNEC undergo proliferation with concomitant increase in NE marker expression. 6 Although the levels of NE cells were lower in Gfi1 À/À mice, the post-naphthalene rate of change between the wt and Gfi1 À/À mice were similar. PNEC proliferation represents only a small fraction of the total number of proliferating cells after naphthalene injury. 11 No effect was observed on the fold increase in PNEC numbers between wt and Gfi1 À/À mice. Thus, whereas Gfi1 appears to be critical for the differentiation of the majority of PNEC, a small subset of Gfi1 À/À PNEC are capable of NE differentiation. Although such PNEC have impaired proliferation, their response to postnaphthalene cues is not statistically different from PNEC in wt littermates. Importantly, the reduced proliferation seen in Gfi1 À/À NE cells is consistent with the previously proposed role for Gfi1 in controlling neuroendocrine cancer growth. 31 Following naphthalene injury, the airways undergo dynamic regeneration characterized by reconstitution of depleted Clara cells. 6 Staining of cells that have incorporated BrdU is representative of cell proliferation in the reconstituting lungs. We find a markedly reduced induction in the overall proliferation rate in the airway epithelium in Gfi1 À/À mice after naphthalene treatment. The reduced proliferation and apoptosis of Gfi1 À/À airway epithelium was associated with a profound impairment in the absolute levels of NE marker expression and BrdU þ CGRP þ cells. Although these results might support a previously hypothesized paracrine and growth stimulatory role of PNEC, 7 we found no difference in the post-naphthalene induced rate of proliferation and apoptosis in wt vs Gfi1 À/À terminal airway epithelial cells. Moreover, regeneration of the CC10 þ cells was virtually identical between wt and Gfi1 À/À littermates. Thus, the data fail to argue conclusively that the NE phenotype (or Gfi1) modulates the regeneration process in bronchioloalveolar junctions following naphthalene-induced injury.
As reported by others, the regeneration at bronchioloalveolar junction may be independent of PNECs. 18, 20 Although PNEC do not function as progenitors in the reconstitution process, 16, 17, 19 the relevant progenitor cells have been suggested to enter a transient NE differentiation phase before differentiating to Clara cells, and even to be the potential progenitors for SCLC. 34 Although the NE phenotype is central to SCLC oncogenesis, 22, 32 our data indicate that it is not likely to be a driving force in the process of postnaphthalene reconstitution.
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